O papel da atenção farmacêutica nos riscos do uso de emagrecedores

Abstract

The increasing number of overweight and obese people has increased the use of slimming drugs, thus turning the attention of regulatory bodies and the scientific community to the problem. Pharmaceutical care helps to deal with this problem that is increasingly common in the Brazilian population. The aim of this article is to discuss the risks of indiscriminate use of weight-loss drugs and the role of pharmaceutical care in raising awareness for the correct use of such drugs and in the containment of self-medication. The method used to write this article was the bibliographic review, based on the reading and analysis of scientific articles, monographs, master's dissertations and doctoral theses in the area of Health Sciences. As a result, we observe the role of the pharmacist in society, as a true counselor on health issues and on combating self-medication. The most common drugs used for weight loss in the country are: sibutramine, liraglutina, orlistat and amphetamines and have risks and adverse effects. It can be concluded that the pharmacist, via pharmaceutical care, is the most prepared health professional to deal with issues related to the use of medications, and more specifically weight loss professionals.